The impact of cognitive challenges in major depression: the role of the primary care physician

References

• Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095–3105.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Soczynska JZ, Woldeyohannes HO, et al. The impact of cognitive impairment on perceived workforce performance: results from the International Mood Disorders Collaborative Project. Compr Psychiatry. 2015;56:279–282.
   PubMed Web of Science ®Google Scholar
• Rock PL, Roiser JP, Riedel WJ, et al. Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2014;44(10):2029–2040.
   PubMed Web of Science ®Google Scholar
• Birnbaum HG, Kessler RC, Kelley D, et al. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depress Anxiety. 2010;27(1):78–89.
   PubMed Web of Science ®Google Scholar
• Buist-Bouwman MA, Ormel J, De Graaf R, et al. Mediators of the association between depression and role functioning. Acta Psychiatr Scand. 2008;118(6):451–458.
   PubMed Web of Science ®Google Scholar
• Collins PY, Patel V, Joestl SS, et al. Grand challenges in global mental health. Nature. 2011;475(7354):27–30.
   PubMed Web of Science ®Google Scholar
• Keefe RS, McClintock SM, Roth RM, et al. Cognitive effects of pharmacotherapy for major depressive disorder: a systematic review. J Clin Psychiatry. 2014;75(8):864–876.
   PubMed Web of Science ®Google Scholar
• Fried EI, Nesse RM. Depression is not a consistent syndrome: an investigation of unique symptom patterns in the STAR*D study. J Affect Disord. 2015;172:96–102.
   PubMed Web of Science ®Google Scholar
• Insel TR. Beyond efficacy: the STAR*D trial. Am J Psychiatry. 2006;163(1):5–7.
   PubMed Web of Science ®Google Scholar
• Conradi HJ, Ormel J, De Jonge P. Presence of individual (residual) symptoms during depressive episodes and periods of remission: a 3-year prospective study. Psychol Med. 2011;41(6):1165–1174.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington (DC): American Psychiatric Press, Inc; 2013.
   Google Scholar
• Mayberg HS, Liotti M, Brannan SK, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. Am J Psychiatry. 1999;156(5):675–682.
   PubMed Web of Science ®Google Scholar
• Giacobbe P, Mayberg HS, Lozano AM. Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol. 2009;219(1):44–52.
   PubMed Web of Science ®Google Scholar
• Wang L, Potter GG, Krishnan RK, et al. Neural correlates associated with cognitive decline in late-life depression. Am J Geriatr Psychiatry. 2012;20(8):653–663.
   PubMed Web of Science ®Google Scholar
• Elgamal S, Denburg S, Marriott M, et al. Clinical factors that predict cognitive function in patients with major depression. Can J Psychiatry. 2010;55(10):653–661.
   PubMed Web of Science ®Google Scholar
• McKenzie K, Sharples P, Murray AL. Validating the learning disability screening questionnaire against the wechsler adult intelligence scale, fourth edition. Intellect Dev Disabil. 2015;53(4):301–307.
   PubMed Web of Science ®Google Scholar
• Canivez GL, Watkins MW, Dombrowski SC. Factor structure of the wechsler intelligence scale for children-fifth edition: exploratory factor analysis with the 16 primary and secondary subsets. Psychol Assess. 2015 Nov 16. doi:10.1037/pas0000358
   PubMed Web of Science ®Google Scholar
• Jiang W, Li Y, Du Y, et al. Emotional regulation and executive function deficits in unmedicated Chinese children with oppositional defiant disorder. Psychiatry Investig. 2016;13(3):277–287.
   PubMed Web of Science ®Google Scholar
• Garcia M, Montalvo I, Creus M, et al. Sex differences in the effect of childhood trauma on the clinical expression of early psychosis. Compr Psychiatry. 2016;68:86–96.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Depression Fact Sheet [Internet]. Geneva (Switzerland); 2012. Available from: http://www.who.int/mediacentre/events/2012/wha65/journal/en/index4.html
   Google Scholar
• Matcham F, Norton S, Steer S, et al. Usefulness of the SF-36 health survey in screening for depressive and anxiety disorders in rheumatoid arthritis. BMC Musculoskelet Disord. 2016;17(1):224.
   PubMed Web of Science ®Google Scholar
• Burkauskas J, Brozaitiene J, Bunevicius A, et al. Association of depression, anxiety, and type D personality with cognitive function in patients with coronary artery disease. Cogn Behav Neurol. 2016;29(2):91–99.
   PubMed Web of Science ®Google Scholar
• Bhargav P, Bhargav H, Raghuram N, et al. Immediate effect of two yoga-based relaxation techniques on cognitive functions in patients suffering from relapsing remitting multiple sclerosis: A comparative study. Int Rev Psychiatry. 2016;28(3):299–308.
   PubMed Web of Science ®Google Scholar
• Ullmann G. Case report: outcomes of feldenkrais movements on self-reported cognitive decline in older adults. Adv Mind Body Med. 2016;30(2):19–23.
   PubMedGoogle Scholar
• Shilyansky C, Williams LM, Gyurak A, et al. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study. The Lancet Psychiatry. 2016;3(5):425–435.
   PubMed Web of Science ®Google Scholar
• Herzallah MM, Moustafa AA, Natsheh JY, et al. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. J Affect Disord. 2013;151(2):484–492.
   PubMed Web of Science ®Google Scholar
• Carlini VP, Poretti MB, Rask-Andersen M, et al. Differential effects of fluoxetine and venlafaxine on memory recognition: possible mechanisms of action. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38(2):159–167.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol. 2016;19(2):1–13.
   Web of Science ®Google Scholar
• Raskin J, Wiltse CG, Siegal A, et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am J Psychiatry. 2007;164(6):900–909.
   PubMed Web of Science ®Google Scholar
• Robinson M, Oakes TM, Raskin J, et al. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Am J Geriatr Psychiatry. 2014;22(1):34–45.
   PubMed Web of Science ®Google Scholar
• Ferguson JM, Wesnes KA, Schwartz GE. Reboxetine versus paroxetine versus placebo: effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol. 2003;18(1):9–14.
   PubMed Web of Science ®Google Scholar
• Georgotas A, McCue RE, Reisberg B, et al. The effects of mood changes and antidepressants on the cognitive capacity of elderly depressed patients. Int Psychogeriatr. 1989;1(2):135–143.
   PubMedGoogle Scholar
• Bondareff W, Alpert M, Friedhoff AJ, et al. Comparison of sertraline and nortriptyline in the treatment of major depressive disorder in late life. Am J Psychiatry. 2000;157(5):729–736.
   PubMed Web of Science ®Google Scholar
• Culang-Reinlieb ME, Sneed JR, Keilp JG, et al. Change in cognitive functioning in depressed older adults following treatment with sertraline or nortriptyline. Int J Geriatr Psychiatry. 2012;27(8):777–784.
   PubMed Web of Science ®Google Scholar
• Soczynska JK, Ravindran LN, Styra R, et al. The effect of bupropion XL and escitalopram on memory and functional outcomes in adults with major depressive disorder: results from a randomized controlled trial. Psychiatry Res. 2014;220(1–2):245–250.
   PubMed Web of Science ®Google Scholar
• Gorlyn M, Keilp J, Burke A, et al. Treatment-related improvement in neuropsychological functioning in suicidal depressed patients: paroxetine vs. bupropion. Psychiatry Res. 2015;225(3):407–412.
   PubMed Web of Science ®Google Scholar
• Levkovitz Y, Caftori R, Avital A, et al. The SSRIs drug fluoxetine, but not the noradrenergic tricyclic drug desipramine, improves memory performance during acute major depression. Brain Res Bull. 2002;58(4):345–350.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lophaven S, Olsen CK. A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol. 2014;17(10):1557–1567.
   PubMed Web of Science ®Google Scholar
• Katona C, Hansen T, Olsen CK. A randomized, double-blind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol. 2012;27(4):215–223.
   PubMed Web of Science ®Google Scholar
• Mahableshwarkar AR, Zajecka J, Jacobson W, et al. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology. 2015;40:1–13.
   PubMed Web of Science ®Google Scholar
• Leiser SC, Li Y, Pehrson AL, et al. Serotonergic regulation of prefrontal cortical circuitries involved in cognitive processing: a review of individual 5-HT receptor mechanisms and concentrated effects of 5-HT receptors exemplified by the multimodal antidepressant vortioxetine. ACS Chem Neurosci. 2015;6(7):970–986.
   PubMed Web of Science ®Google Scholar
• Du Jardin KG, Müller HK, Sanchez C, et al. A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex. Eur J Pharmacol. 2016;786:29–35.
   PubMed Web of Science ®Google Scholar
• Swanson CJ, Perry KW, Koch-Krueger S, et al. Effect of the attention deficit/hyperactivity disorder drug atomoxetine on extracellular concentrations of norepinephrine and dopamine in several brain regions of the rat. Neuropharmacology. 2006;50(6):755–760.
   PubMed Web of Science ®Google Scholar
• Wilens TE, Haight BR, Horrigan JP, et al. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo controlled study. Biol Psychiatry. 2005;57(7):793–801.
   PubMed Web of Science ®Google Scholar
• McIntyre RS, Lee Y, Mansur RB. Treating to target in major depressive disorder: response to remission to functional recovery: CNS Spectr. 2015;12:20–30.
   Google Scholar
• Biederman J, Swanson JM, Wigal SB, et al. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study. Pediatrics. 2005;116(6):777–784.
   PubMed Web of Science ®Google Scholar